首页 正文

Gastrointestinal stromal tumors: who should get imatinib and for how long?

{{output}}
The application of imatinib for the treatment of GIST remains a remarkable illustration of the ability and promise of targeted molecular therapy. It is gradually becoming evident that the benefit of imatinib depends on the complex interplay between mutational ... ...